Evidence map›Paper›PMID 28416699›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

IP

Kozo Hamada, Hideyuki Miyatake, Akiko Terauchi, Katsuhiko Mikoshiba

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Structural titration reveals CaNature communications · 2023
    Article
  6. Article
  7. Functional determination of calcium-binding sites required for the activation of inositol 1,4,5-trisphosphate receptors.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. IPProgress in molecular and subcellular biology · 2021
    Review
  15. Overview of CaExploration of targeted anti-tumor therapy · 2021
    Review
  16. Article
  17. Astrocytic IPFrontiers in cellular neuroscience · 2021
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kozo HamadaLaboratory for Developmental Neurobiology, Brain Science Institute, RIKEN, Saitama 351-0198, Japan.
Hideyuki MiyatakeNano Medical Engineering Laboratory, RIKEN, Saitama 351-0198, Japan.
Akiko TerauchiLaboratory for Developmental Neurobiology, Brain Science Institute, RIKEN, Saitama 351-0198, Japan.
Katsuhiko MikoshibaLaboratory for Developmental Neurobiology, Brain Science Institute, RIKEN, Saitama 351-0198, Japan; mikosiba@brain.riken.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The inositol 1,4,5-trisphosphate (IP

Indexed as

Ion Channel GatingAllosteric RegulationAnimalsCrystallography, X-RayHumansInositol 1,4,5-TrisphosphateInositol 1,4,5-Trisphosphate ReceptorsMiceProtein DomainsProtein Structure, SecondaryStructure-Activity RelationshipInositol 1,4,5-TrisphosphateInositol 1,4,5-Trisphosphate Receptorsallosteric regulationcalcium channelgating mechanismIP3 receptorX-ray crystallography

Identifiers

PMID28416699
PMCPMC5422816

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.